vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与SEACOR Marine Holdings Inc.（SMHI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是SEACOR Marine Holdings Inc.的1.4倍（$75.5M vs $52.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -25.0%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-20.6M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -8.7%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
SEACOR Marine Holdings总部位于美国佛罗里达州劳德代尔堡，主要为海上石油行业以及海运行业提供相关设备与服务，作为美国企业，该公司持有伊利诺伊州一座生物乙醇工厂70%的股权。
PBYI vs SMHI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$52.3M
营收增速更快
PBYI
高出52.8%
-25.0%
自由现金流更多
PBYI
多$35.0M
$-20.6M
两年增速更快
PBYI
近两年复合增速
-8.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $52.3M |
| 净利润 | — | $-14.6M |
| 毛利率 | 69.3% | 18.5% |
| 营业利润率 | 22.7% | -9.9% |
| 净利率 | — | -27.9% |
| 营收同比 | 27.7% | -25.0% |
| 净利润同比 | — | 44.2% |
| 每股收益（稀释后） | $0.26 | $-0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISMHI
| Q4 25 | $75.5M | $52.3M | ||
| Q3 25 | $54.5M | $59.2M | ||
| Q2 25 | $52.4M | $60.8M | ||
| Q1 25 | $46.0M | $55.5M | ||
| Q4 24 | $59.1M | $69.8M | ||
| Q3 24 | $80.5M | $68.9M | ||
| Q2 24 | $47.1M | $69.9M | ||
| Q1 24 | $43.8M | $62.8M |
净利润PBYISMHI
| Q4 25 | — | $-14.6M | ||
| Q3 25 | $8.8M | $9.0M | ||
| Q2 25 | $5.9M | $-6.7M | ||
| Q1 25 | $3.0M | $-15.5M | ||
| Q4 24 | — | $-26.2M | ||
| Q3 24 | $20.3M | $-16.3M | ||
| Q2 24 | $-4.5M | $-12.5M | ||
| Q1 24 | $-4.8M | $-23.1M |
毛利率PBYISMHI
| Q4 25 | 69.3% | 18.5% | ||
| Q3 25 | 77.7% | 19.4% | ||
| Q2 25 | 76.5% | 18.6% | ||
| Q1 25 | 77.1% | 24.5% | ||
| Q4 24 | 76.4% | 33.1% | ||
| Q3 24 | 63.9% | 23.2% | ||
| Q2 24 | 77.4% | 29.1% | ||
| Q1 24 | 75.5% | 23.4% |
营业利润率PBYISMHI
| Q4 25 | 22.7% | -9.9% | ||
| Q3 25 | 17.6% | 30.5% | ||
| Q2 25 | 12.7% | 10.0% | ||
| Q1 25 | 8.7% | -9.5% | ||
| Q4 24 | 22.6% | 15.2% | ||
| Q3 24 | 27.4% | -9.4% | ||
| Q2 24 | -4.6% | -5.6% | ||
| Q1 24 | -5.3% | -16.9% |
净利率PBYISMHI
| Q4 25 | — | -27.9% | ||
| Q3 25 | 16.2% | 15.2% | ||
| Q2 25 | 11.2% | -11.1% | ||
| Q1 25 | 6.5% | -27.9% | ||
| Q4 24 | — | -37.6% | ||
| Q3 24 | 25.2% | -23.7% | ||
| Q2 24 | -9.6% | -17.9% | ||
| Q1 24 | -11.0% | -36.8% |
每股收益（稀释后）PBYISMHI
| Q4 25 | $0.26 | $-0.59 | ||
| Q3 25 | $0.17 | $0.35 | ||
| Q2 25 | $0.12 | $-0.26 | ||
| Q1 25 | $0.06 | $-0.56 | ||
| Q4 24 | $0.40 | $-0.94 | ||
| Q3 24 | $0.41 | $-0.59 | ||
| Q2 24 | $-0.09 | $-0.45 | ||
| Q1 24 | $-0.10 | $-0.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $68.9M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $264.4M |
| 总资产 | $216.3M | $660.6M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYISMHI
| Q4 25 | $97.5M | $68.9M | ||
| Q3 25 | $94.4M | $91.0M | ||
| Q2 25 | $96.0M | $34.4M | ||
| Q1 25 | $93.2M | $43.0M | ||
| Q4 24 | $101.0M | $59.5M | ||
| Q3 24 | $96.7M | $35.6M | ||
| Q2 24 | $96.8M | $40.6M | ||
| Q1 24 | $107.2M | $59.6M |
总债务PBYISMHI
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYISMHI
| Q4 25 | $130.3M | $264.4M | ||
| Q3 25 | $115.3M | $277.3M | ||
| Q2 25 | $104.7M | $267.5M | ||
| Q1 25 | $97.1M | $283.7M | ||
| Q4 24 | $92.1M | $298.0M | ||
| Q3 24 | $71.1M | $324.7M | ||
| Q2 24 | $48.5M | $337.6M | ||
| Q1 24 | $51.0M | $348.5M |
总资产PBYISMHI
| Q4 25 | $216.3M | $660.6M | ||
| Q3 25 | $202.9M | $692.5M | ||
| Q2 25 | $194.9M | $680.0M | ||
| Q1 25 | $196.2M | $694.2M | ||
| Q4 24 | $213.3M | $727.1M | ||
| Q3 24 | $220.7M | $709.4M | ||
| Q2 24 | $205.0M | $721.6M | ||
| Q1 24 | $214.1M | $744.8M |
负债/权益比PBYISMHI
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-12.2M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $-20.6M |
| 自由现金流率自由现金流/营收 | 19.1% | -39.4% |
| 资本支出强度资本支出/营收 | 0.0% | 16.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $-85.2M |
8季度趋势，按日历期对齐
经营现金流PBYISMHI
| Q4 25 | $14.4M | $-12.2M | ||
| Q3 25 | $9.7M | $-10.7M | ||
| Q2 25 | $14.1M | $-2.1M | ||
| Q1 25 | $3.6M | $-11.5M | ||
| Q4 24 | $15.6M | $8.5M | ||
| Q3 24 | $11.0M | $626.0K | ||
| Q2 24 | $1.0M | $-12.2M | ||
| Q1 24 | $11.2M | $-7.2M |
自由现金流PBYISMHI
| Q4 25 | $14.4M | $-20.6M | ||
| Q3 25 | $9.7M | $-20.0M | ||
| Q2 25 | $14.1M | $-12.3M | ||
| Q1 25 | $3.6M | $-32.3M | ||
| Q4 24 | $15.6M | $5.5M | ||
| Q3 24 | $11.0M | $416.0K | ||
| Q2 24 | $1.0M | $-12.9M | ||
| Q1 24 | — | $-10.6M |
自由现金流率PBYISMHI
| Q4 25 | 19.1% | -39.4% | ||
| Q3 25 | 17.7% | -33.8% | ||
| Q2 25 | 26.8% | -20.2% | ||
| Q1 25 | 7.7% | -58.1% | ||
| Q4 24 | 26.4% | 7.9% | ||
| Q3 24 | 13.7% | 0.6% | ||
| Q2 24 | 2.1% | -18.5% | ||
| Q1 24 | — | -16.9% |
资本支出强度PBYISMHI
| Q4 25 | 0.0% | 16.1% | ||
| Q3 25 | 0.0% | 15.8% | ||
| Q2 25 | 0.0% | 16.8% | ||
| Q1 25 | 0.1% | 37.5% | ||
| Q4 24 | 0.0% | 4.3% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.9% | ||
| Q1 24 | 0.0% | 5.4% |
现金转化率PBYISMHI
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | -1.19× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
